Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a significant advance in addressing excess weight. Early study data have demonstrated https://desert-stardust-mushroom395046.bloggingthecity.com/90735/emerging-medication-in-australia-a-potential-breakthrough-for-reducing-body-weight